Product Reports Resources Pricing Login Book a demo

Caresyntax

Health Tech & Medtech · Boston, United States · Founded 2013

Digital surgery platform that uses proprietary software and AI to deliver actionable insights to improve patient outcomes MoreLess

Caresyntax is a healthcare technology startup that operates in the surgical data analytics space. The company provides software, data, and professional services solutions to optimize surgical procedures, improve patient outcomes, and enhance operational efficiency in hospitals and clinics. Its primary clients are surgeons and their teams, as well as large, for-profit hospitals and university hospitals.

Caresyntax's business model revolves around its vendor-neutral, enterprise-scale surgical technology data platform. This platform collects and analyzes data from surgical procedures to support decision-making, enhance surgical techniques, and improve team dynamics. The goal is to reduce unwarranted variation in surgical procedures, thereby increasing patient safety and satisfaction.

The company also offers video-based assessments and analytics to improve surgical skills and team dynamics. These services have been used by institutions such as the University of Iowa Hospitals and Clinics and the Hôpitaux Universitaires de Strasbourg to improve their surgical procedures.

Caresyntax generates revenue by selling its software and services to hospitals and clinics. The company's solutions have been deployed in 2,800 operating rooms worldwide, supporting more than 32,000 surgical teams and improving care for more than 3 million patients per year.

In summary, Caresyntax is a healthcare technology company that uses data analytics to improve surgical procedures and patient outcomes, while also enhancing operational efficiency in hospitals and clinics.

Keywords: Healthcare Technology, Data Analytics, Surgical Procedures, Patient Outcomes, Operational Efficiency, Vendor-Neutral Platform, Video-Based Assessments, Surgical Teams, For-Profit Hospitals, University Hospitals.

Valuation $500M–1B
Revenue $10–50M
Headcount 100–500
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Caresyntax and the history behind them.

Talent graph

Caresyntax's talent

Book a demo to see the people
Employees mapped 139 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

21 investors on Caresyntax's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage
Norgine Ventures
Surgical.AI
Plug and Play
IPF Partners
Mitsubishi
Whiz Partners
Series B+ 15 investors entered at this stage
PFM Health Sciences
Lauxera Capital Partners
Intel Capital
Optum Ventures
Harmonix
Arno Capital
BlackRock
ProAssurance
Relyens
Vesalius Biocapital Partners
Rezayat Investments
MTIP
Symbiotic Capital
Pictet
Aescuvest

Global footprint

Where Caresyntax has talent and traffic

Workforce by country
12 countries with
team presence
🇩🇪 Germany46.2%
🇺🇸 United States37.7%
🇫🇷 France5.7%
🇬🇧 United Kingdom1.9%
🇨🇦 Canada1.9%
Top 5 of 12 shown
Web traffic by country
14K monthly visits
across markets
🇺🇸 United States85%
🇩🇪 Germany5%
🇮🇳 India3.6%
🇬🇧 United Kingdom2.9%
🇪🇬 Egypt1.4%
Top 5 markets shown

Market sentiment

What the market is saying about Caresyntax

An AI-synthesized read of the highest-engagement posts about Caresyntax on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Caresyntax on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.